Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Asset Writedowns and Impairment (2024)

Historic Asset Writedowns and Impairment for Bioadaptives (BDPT) over the last 1 years, with Q3 2024 value amounting to $60000.0.

  • Bioadaptives' Asset Writedowns and Impairment changed N/A to $60000.0 in Q3 2024 from the same period last year, while for Sep 2025 it was $60000.0, marking a year-over-year change of. This contributed to the annual value of $81350.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Bioadaptives reported Asset Writedowns and Impairment of $60000.0 as of Q3 2024.
  • Bioadaptives' Asset Writedowns and Impairment's 5-year high stood at $60000.0 during Q3 2024, with a 5-year trough of $60000.0 in Q3 2024.